Here, we demonstrated that immunocompromised patients, CVID and KTR, after the third dose of mRNA COVID-19 vaccine had lower levels of serum IgG directed against the (trimeric) SARS-CoV-2 Spike-protein compared to healthy controls. Here, CHMP5 is linked to common variable immunodeficiency.